ClinicalTrials.gg
Status unknownNCT04177550Updated Nov 29, 2019

Early Results of Empyema Thoracis Treatment in Children by Video-assisted Thoracoscopic Surgery

An observational study in Empyema Thoracis in Children, sponsored by Nhan Pham Nguyen Hien. Status unknown at 1 site in Vietnam. Open to participants aged Up to 16 Years. Per ClinicalTrials.gov, last updated 2019-11-29.

Sponsored by Nhan Pham Nguyen Hien · Observational

The sponsor has not verified this record recently (last verified Nov 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-crossover
Time perspective
Retrospective
Enrollment
44
Ages
Up to 16 Years
Sex
All
01

Study summary

The aim of study is to assess early results of Empyema Thoracis treatment in Children by Video-assisted Thoracoscopic Surgery

02

Conditions studied

  • Empyema Thoracis in Children

Browse trials for

Keywords

  • empyema thoracis
  • Thoracoscopic
  • VATS
  • Video-assisted Thoracoscopic Surgery
  • Pediatric Empyema Thoracis
03

In context

Empyema

38 studies on the registry are indexed under Empyema; 11 are open to participants now.

Browse Empyema studies →

Lead sponsor

This is the only study on the registry with Nhan Pham Nguyen Hien as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The patient had empyema who treated by Video-assisted Thoracoscopic Surgery in Children hospital 1 from 01/01/2015 to 30/04/2019

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients had empyema.
  • All patients had been treated by Video-assisted Thoracoscopic Surgery in Children hospital 1 from 01/01/2015 to 30/04/2019.

Exclusion criteria

Exclusion Criteria:

  • The patient had empyema caused by Tuberculosis.
05

Study design

Observational model
Case-crossover
Time perspective
Retrospective
Enrollment
44 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Recover

    Time of operation

    Time frame: 2 hours

07

Study locations

1 site
  • Children hospital no.1
    Ho Chi Minh City, Vietnam
08

References and documents

Individual participant data

Plan to share: Undecided — We will decide when the research is complete

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04177550
Lead sponsor
Nhan Pham Nguyen Hien
Collaborators
Ho Trung Cuong, Trinh Nguyen Ha Vi, Tran Nhu Quynh, Vu Minh Thuy, Nguyen Thi Tuong Lam
Responsible party
Nhan Pham Nguyen Hien (Principal Investigator, University of Medicine and Pharmacy at Ho Chi Minh City) — Sponsor-investigator
First posted
Nov 26, 2019
Start date
Dec 21, 2019 (estimated)
Primary completion
Dec 21, 2019 (estimated)
Completion
May 21, 2020 (estimated)
Last update
Nov 29, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion